Redi

Surfside Pioneers New Era of Cannabis Advertising with State-of-the-Art Commerce Media Technology

Retrieved on: 
Tuesday, August 29, 2023
Advertising, Noise, Redi, Marketing, Sale, SKU, Entrepreneurship, ROI, Economics, Online shopping

NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Surfside Solutions Inc. ("Surfside"), building the next generation of advertising technology to help reach customers with personalized marketing, today announced the national launch of its latest product offering, Commerce Media.

Key Points: 
  • National launch of Commerce Media allows retailers the ability to monetize their online and in-store shelf space with brand sponsored ad placements and product listings.
  • NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Surfside Solutions Inc. ("Surfside"), building the next generation of advertising technology to help reach customers with personalized marketing, today announced the national launch of its latest product offering, Commerce Media.
  • In private beta since April 2023, this innovative solution empowers cannabis brands by opening a new advertising channel directly within a retailer's ecommerce websites and marketplaces.
  • To learn more about Surfside's new offerings or schedule a demo, email [email protected] or visit us at https://www.surfside.io/commerce-media .

Kojamo plc's Financial Statements Release 1 January-31 December 2022

Retrieved on: 
Wednesday, February 15, 2023
Eurobond, Uncertainty, Key, Trust, Tenant, Investment, Lumo, Electricity, ID, Maintenance, News, Kalasatama, Webcast, EUR, Metropolia, Redi, EET, Marketing, Growth, Chemistry, Environment, COVID-19, Nasdaq Helsinki, Mannerheimintie, FFO, History, Renting, Retail, Tourism

HELSINKI, Feb. 15, 2023 /PRNewswire/ -- This is a summary of the 2022 Financial Statements Release, which is in its entirety attached to this release and can be downloaded from the company's website at www.kojamo.fi/investors.

Key Points: 
  • In addition, Kojamo estimates that the Group's FFO for 2023 will amount to between EUR 153–165 million, excluding non-recurring items.
  • Total revenue, net rental income and FFO increased, and our financial position has remained strong.
  • As we anticipated, COVID-19 pandemic had only a temporary effect on the migration towards the biggest growth centres.
  • The demand in the rental market improved after the prolonged uncertainty caused by the pandemic began to dissipate, and urbanisation continued.

Red Roof® 'Room in Your Heart' Campaign Once Again Supports Canine Companions® in February, Aiming to Raise $50,000

Retrieved on: 
Wednesday, February 1, 2023
Room in Your Heart, Disability, Veteran, Red, Travel, Roof, Red Roof Inn, Redi, Canine, Dog, Room, Vaccine

COLUMBUS, Ohio, Feb. 1, 2023 /PRNewswire/ -- Red Roof®, an award-winning leader in the lodging industry, is once again partnering with Canine Companions® for its latest 'Room in Your Heart' (RIYH) purpose-driven promotion. Travelers who book and stay at Red Roof from February 1, 2023, through February 28, 2023, can save 15% on their stay, and a percentage of the purchase price from that completed stay will be donated to Canine Companions.

Key Points: 
  • Canine Companions transforms the lives of people with disabilities by providing their clients with expertly trained service dogs, free of charge.
  • "We are grateful for the ongoing support of Red Roof and travelers who support Canine Companions as they travel in February."
  • That donation qualified Red Roof to name a Canine Companions puppy, which was named Redi.
  • In honor of its 50th anniversary, Red Roof is once again, with guests' help, hoping to raise another $50,000 this year, and name another heroic Canine Companions puppy.

Redi.Health Announces Top Digital Patient Engagement Trends For 2023

Retrieved on: 
Wednesday, December 21, 2022
Quality of life, Digital technology, Pharma, Diet, Health, Patient, Architecture, Digital, Pharmacotherapy, COVID-19, PSP, Nature, Checklist, Digital health, Prevalence, CB Insights, Conditional sentence, Redi, Exercise, Workflow, Medical device, Health insurance, Pharmaceutical industry

COLUMBUS, Ohio, Dec. 21, 2022 /PRNewswire-PRWeb/ -- Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing five digital patient engagement trends for the year ahead.

Key Points: 
  • COLUMBUS, Ohio, Dec. 21, 2022 /PRNewswire-PRWeb/ -- Today, Redi.Health , provider of the leading health management technology that puts patient support in your pocket, is announcing five digital patient engagement trends for the year ahead.
  • In 2023, manufacturers must join the digital age and allow patients to connect with them directly for enhanced support and seamless care.
  • By embracing the digital experience, manufacturers will ultimately have new opportunities to connect with patients with who they previously had little or no engagement with in the past.
  • All-in-one digital health platforms: These trends for 2023 and beyond lead to increased demand and prevalence for "all-in-one" digital health platforms.

ScriptDrop and Redi.Health Partner to Improve Long-Term Health Outcomes

Retrieved on: 
Wednesday, November 2, 2022
Patient, Prescription, Pharmacist, Gaps, PBM, CEO, Health, Quality of life, CoverMyMeds, Redi, Partnership, Pharmaceutical industry, Medical device

COLUMBUS, Ohio, Nov. 2, 2022 /PRNewswire-PRWeb/ -- Today, ScriptDrop Inc., a healthcare technology company focused on nationwide prescription access, and Redi.Health, provider of the leading health management technology that puts patient support in your pocket, are announcing a strategic partnership that improves patient access to information and provides tools that help them manage their prescriptions, and thus, their quality of life.

Key Points: 
  • "Both leadership teams include alumni of CoverMyMeds, and also share a mission of helping patients remain adherent to their prescriptions, while improving their long-term health outcomes," said Amanda Epp, CEO of ScriptDrop.
  • "We fill in different gaps in the patient experience, so together, we're really completing the circuit of healthcare."
  • With this partnership, Redi.Health and ScriptDrop are delivering a streamlined solution for patients, providers, pharmacists, PBMs, and pharmaceutical manufacturers to better understand and manage medications.
  • This pairing will ensure patients have dependable access to prescriptions and can improve their health outcomes, while also helping build trust between patients and pharmaceutical manufacturers.

Redi.Health Sees Tremendous Growth for Platform that Empowers Patients to Understand, Manage and Track their Health with Digital Support

Retrieved on: 
Monday, October 17, 2022
Adoption, Quality of life, Technology, Growth, MCP, Redi, Patient, Exercise, Industry, CEO, M25, Diet, GoodRx, LabCorp, Health insurance, Health

COLUMBUS, Ohio, Oct. 17, 2022 /PRNewswire-PRWeb/ -- Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing it has secured growth capital led by Refinery Ventures, with participation from repeat investors MCP, Rev1 Ventures, and M25. The funding follows the company's recent seed financing round and helps support increased demand for the platform, which has seen continued adoption from patients across the nation.

Key Points: 
  • The funding follows the company's recent seed financing round and helps support increased demand for the platform, which has seen continued adoption from patients across the nation.
  • Redi.Health combines health management technology and pharmaceutical manufacturer support into one platform to enable patients to manage their complete health with a single interface.
  • Redi.Health empowers patients with chronic conditions to understand, manage and track their total health through digital support.
  • By delivering a pathway for pharmaceutical companies, providers, and patients to connect and engage, Redi.Health customizes the complete health journey to drive better health outcomes.

Redi.Health Executive Confirmed as Speaker for Leading Pharmaceutical Conference

Retrieved on: 
Wednesday, October 12, 2022
Health care, Conference, Patient, Redi, Health, Contract, Entrepreneurship, Exercise, Industry, Diet, Digital, Pharmaceutical industry, Medical device

COLUMBUS, Ohio, Oct. 12, 2022 /PRNewswire-PRWeb/ -- Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing that Co-Founder and CEO Luke Buchanan will be speaking at the Access Insights Conference in Baltimore next week. The three-day conference, designed for commercial, operational, and financial teams at pharmaceutical manufacturers, will feature industry executive and practitioner panels, including strategic and tactical programs focused on driving patient access and therapy commercialization. Buchanan will participate in two panel discussions to share strategies for implementing total health management through digital platforms.

Key Points: 
  • The three-day conference, designed for commercial, operational, and financial teams at pharmaceutical manufacturers, will feature industry executive and practitioner panels, including strategic and tactical programs focused on driving patient access and therapy commercialization.
  • Buchanan will participate in two panel discussions to share strategies for implementing total health management through digital platforms.
  • The Patient as a Consumer: Meeting Evolving Expectations in Healthcare Accessibility
    To register or for more information about the Access Insights Conference, click here .
  • By delivering a pathway for pharmaceutical companies, providers, and patients to connect and engage, Redi.Health customizes the complete health journey to drive better health outcomes.

Redi.Health Collaborates with Labcorp to Seamlessly Connect Patients and Providers

Retrieved on: 
Tuesday, July 12, 2022
LabCorp, Ensuring Patient Access and Effective Drug Enforcement Act, Technology, CEO, Quality of life, Health, Biotechnology, Redi, Patient, Solution, Healthcare, Medical device

COLUMBUS, Ohio, July 12, 2022 /PRNewswire-PRWeb/ -- Today, Redi.Health, provider of health management technology that improves total patient health, is announcing a collaboration with Labcorp, a leading global life sciences company. Through this combined effort, Labcorp Drug Development's Patient Access Solutions will integrate Redi.Health's digital support platform to offer patients and their care providers a variety of digital and traditional communications channels and tools with real-time data synching to help patients better manage their health.

Key Points: 
  • Through this combined effort, Labcorp Drug Development 's Patient Access Solutions will integrate Redi.Health's digital support platform to offer patients and their care providers a variety of digital and traditional communications channels and tools with real-time data synching to help patients better manage their health.
  • Labcorp Drug Development's Patient Access Solutions works on behalf of pharmaceutical and biotechnology companies to deliver advanced technology and personal support solutions for patients and providers.
  • The collaboration with Redi.Health features access to support resources for patients who are receiving services through Labcorp Drug Development's Patient Access hub programs, and native app features that allows patients to comprehensively manage their total health and connect with their provider(s).
  • It's simple we believe in patients and give them the tools to take control of their health.

Redi.Health Secures Financing to Accelerate Availability of Health Management Platform for Patients with Chronic Diseases

Retrieved on: 
Wednesday, October 6, 2021
Medication, MCP, Redi, Pharmacy Council of India, Plug and play, Health, Patient, Population, Element, CEO, Growth, Chronemics, Blue Wolf Capital Partners, Technology, Conditional sentence, Economic development, Quality of life, Health insurance, Healthcare

The population of polychronic patients (those with three or more chronic diseases), is expected to triple to nearly 90MM patients in the next decade.

Key Points: 
  • The population of polychronic patients (those with three or more chronic diseases), is expected to triple to nearly 90MM patients in the next decade.
  • For these patients, the management of appointments, medications and daily life is critical.
  • Redi.Health combines health management and partnered pharmaceutical manufacturer support into one tool to deliver a truly patient-centric platform that helps people improve their adherence as well as their quality of life.
  • With this funding from leaders in Ohio and beyond, we're poised to accelerate our commercialization of this very important technology."

sticky.io Closes $90 Million Facility With Goldman Sachs Asset Management

Retrieved on: 
Tuesday, June 8, 2021
Online Retail, Other Retail, Retail, Technology, Software, Goldman Sachs, Subprime mortgage crisis, Financial services, Banks, Finance, Redi, Goldman Sachs controversies, sticky.io, Goldman Sachs Asset Management, STICKY.IO, GOLDMAN SACHS ASSET MANAGEMENT

sticky.io, a leading ecommerce platform provider for subscription management and recurring billing, today announced that it has closed a $90 million material capital transaction with the Private Credit business within Goldman Sachs Asset Management (Goldman Sachs).

Key Points: 
  • sticky.io, a leading ecommerce platform provider for subscription management and recurring billing, today announced that it has closed a $90 million material capital transaction with the Private Credit business within Goldman Sachs Asset Management (Goldman Sachs).
  • Our relationship with Goldman Sachs is a reflection of our evolution in a dynamic industry segment, said Brian Bogosian, president and CEO of sticky.io.
  • Our team is very excited to partner with sticky.io as we see continued opportunities for growth and expanded platform functionality, said Terence Doherty, Managing Director in the Private Credit business within Goldman Sachs Asset Management.
  • Goldman Sachs Asset Management is the primary investing arm of The Goldman Sachs Group, Inc. (NYSE: GS).